Anxiety Disorder Clinical Trial
Verified date | September 2012 |
Source | Meir Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | Israel: Ministry of Health |
Study type | Interventional |
Allergy skin tests are occasionally associated with pain and anxiety in patients undergoing this procedure. The investigators intend to examine if medical clowns compared with local anesthetic cream can decrease these feelings in children.
Status | Completed |
Enrollment | 160 |
Est. completion date | April 2014 |
Est. primary completion date | April 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 1 Year to 18 Years |
Eligibility |
Inclusion Criteria: - Any child undergoing allergy prick skin test Exclusion Criteria: - Children suffering from coulrophobia (phobia of clowns) - Children with a known hypersensitivity to EMLA 5% cream - Children who have undergone a painful medical procedure (surgery, dental procedures, blood drawing) over the past 3 months - Children who, for medical reasons, must have their skin test performed on an area other than the volar aspect of the arm |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Israel | Arnon Goldberg, Allergy and Clinical Immunology Unit, Meir Medical Center | Kfar-Saba |
Lead Sponsor | Collaborator |
---|---|
Meir Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The level of anxiety experienced by children undergoing allergy skin tests and receiving application of local anesthetic cream and/or care and treatment from medical clowns | 1.5 hour | No | |
Secondary | Severity of pain experienced by these children | 1.5 hour | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
Not yet recruiting |
NCT03224845 -
Courageous Parents, Courageous Children
|
N/A | |
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Completed |
NCT02145429 -
Preventing Depression in Late Life: A Model for Low and Middle Income Countries
|
N/A | |
Completed |
NCT00794456 -
Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety
|
Phase 3 | |
Terminated |
NCT00896467 -
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
|
N/A | |
Completed |
NCT00252343 -
Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
|
Phase 3 | |
Not yet recruiting |
NCT05867823 -
OcupApp: Occupational Self-analysis Intervention Through an Mobile Application
|
N/A | |
Recruiting |
NCT04562324 -
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
|
N/A | |
Recruiting |
NCT05989451 -
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders
|
N/A | |
Not yet recruiting |
NCT05488418 -
Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56
|
N/A | |
Not yet recruiting |
NCT03608449 -
Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
|
N/A | |
Completed |
NCT03400397 -
An Effectiveness Study of the Cool Kids Programme
|
N/A | |
Completed |
NCT00025844 -
Fear Conditioning Using Computer-Generated Virtual Reality
|
N/A | |
Completed |
NCT02579928 -
Ketamine Infusion for Adolescent Depression and Anxiety
|
Phase 4 | |
Completed |
NCT02270073 -
The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study
|
N/A | |
Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
Completed |
NCT01721824 -
The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders
|
N/A | |
Completed |
NCT01227980 -
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
|
Phase 2 | |
Completed |
NCT01764789 -
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
|
N/A |